Uncategorized

Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure

Posted on

Last updated: 2019-04-04 April 4, 2019For immediate release OTTAWA – To protect Canadian patients from the rare but serious risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), Health Canada is advising Allergan that the Department intends to suspend its licences for Biocell breast implants as a precautionary measure. This follows the completion of Health […]